BCAB - CIK 0001826892
BioAtla, Inc. (BCAB) reported net income of -$59.61M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$59.61M | +14.6% |
| FY 2024 | -$69.78M | +43.5% |
| FY 2023 | -$123.46M | -15.9% |
| FY 2022 | -$106.48M | -11.6% |
| FY 2021 | -$95.40M | -166.1% |
| FY 2020 | -$35.85M | -20.1% |
| FY 2019 | -$29.86M | - |
BioAtla, Inc. (BCAB) reported net income of -$59.61M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, BioAtla, Inc.'s net income declined from -$29.86M to -$59.61M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.